Immunomodulating Agents

Immunomodulating agents are substances that stimulate or suppresse the immune system and may help the body combat againsts cancer, infection, or other diseases. Discover the latest research on immunomodulating agents here.

October 21, 2021
Preprint
Open Access

Adrenergic signaling controls early transcriptional programs during CD8+ T cell responses to viral infection

BioRxiv : the Preprint Server for Biology
L. EstradaDavid Farrar
October 20, 2021
Preprint
Open Access

Intensive Single Cell Analysis Reveals Immune Cell Diversity among Healthy Individuals

BioRxiv : the Preprint Server for Biology
Y. KashimaYutaka Suzuki
October 19, 2021
Preprint
Open Access

Impact of SARS-CoV-2 infection on longitudinal vaccine immune responses

MedRxiv : the Preprint Server for Health Sciences
S. HavervallCharlotte Thalin
October 19, 2021
Preprint
Open Access

Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer.

BioRxiv : the Preprint Server for Biology
E. A. WellbergErin D Giles
October 18, 2021
Preprint
Open Access

Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine

BioRxiv : the Preprint Server for Biology
K. W. PengStephen J Russell
October 18, 2021
Preprint
Open Access

Reduced seroconversion in children compared to adults with mild COVID-19

MedRxiv : the Preprint Server for Health Sciences
Z. Q. TohPaul Licciardi
October 17, 2021
Preprint
Open Access

An optimized live bacterial delivery platform for the production and delivery of therapeutic nucleic acids and proteins

BioRxiv : the Preprint Server for Biology
D. S. O. MoraLyndsey Linke
October 18, 2021
Preprint
Open Access

Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals

MedRxiv : the Preprint Server for Health Sciences
C. JeewandaraGathsaurie Neelika Malavige
October 17, 2021

Identification of immunodominant epitopes in allelic variants VK210 and VK247 of Plasmodium Vivax Circumsporozoite immunogen.

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Shumaila NazZain Ali
October 16, 2021
Preprint
Open Access

Immunogenic potential of neopeptides depends on parent protein subcellular location

BioRxiv : the Preprint Server for Biology
A. CastroHannah Carter
October 16, 2021
Review

Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19.

Molecular Biology Reports
Azadeh ManayiHamid Reza Khayat Kashani
October 16, 2021
Review

RIPK3 signaling and its role in the pathogenesis of cancers.

Cellular and Molecular Life Sciences : CMLS
Shanhui LiuJiwang Zhang
October 16, 2021

Trastuzumab induced negative chronotropic and lusitropic effects in cynomolgus monkeys.

Journal of Cardiovascular Pharmacology
Tomomichi IshizakaKazuhiko Mori
October 16, 2021

Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis.

Neurology. Neuroimmunology and Neuroinflammation
Camilo E FadulLloyd H Kasper
October 16, 2021
Comment / Editorial

Uncovering the Immunoregulatory Function and Therapeutic Potential of the PD-1/PD-L1 Axis in Cancer.

Cancer Research
Michael R Pitter, Weiping Zou

Sign up to follow this feed and discover related papers.

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Coagulation Products

Coagulation products used to manage bleeding in patients with these disorders include AHF concentrates, factor IX concentrates, factor VIIa concentrate, factor IX complexes, anti-inhibitor coagulant complexes, and desmopressin acetate. Discover the latest research on coagulation products here.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Immuno-Oncology

Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Pharmacological Treatment of Allergies

Allergies, also known as allergic diseases, are a number of conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment. There are various pharmacological treatments for allergy including antihistamines, anti-cholinergics, decongestants, etc. Discover the latest research on pharmacological treatment of allergies here.

Platelet Drugs and Antocoagulants

Antiplatelet drugs decrease platelet aggregation and inhibit thrombus formation while anticoagulants are blood thinners that prolong clotting time. Both agents are amongst the most commonly used medications to reduce coagulation.

© 2021 Meta ULC. All rights reserved
/feed-previews/immunomodulating-agents/df2d654a-0fd3-4ebf-a9d4-79fa66bf1024